SE451798B - Radioaktiv komposition innehallande indium-8-hydroxilandin och sett att merka blodceller - Google Patents

Radioaktiv komposition innehallande indium-8-hydroxilandin och sett att merka blodceller

Info

Publication number
SE451798B
SE451798B SE8009185A SE8009185A SE451798B SE 451798 B SE451798 B SE 451798B SE 8009185 A SE8009185 A SE 8009185A SE 8009185 A SE8009185 A SE 8009185A SE 451798 B SE451798 B SE 451798B
Authority
SE
Sweden
Prior art keywords
indium
radioactive
solution
solutions
radioassay
Prior art date
Application number
SE8009185A
Other languages
English (en)
Swedish (sv)
Other versions
SE8009185L (sv
Inventor
W T Goedemans
Original Assignee
Mallinckrodt Diagnostica Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mallinckrodt Diagnostica Bv filed Critical Mallinckrodt Diagnostica Bv
Publication of SE8009185L publication Critical patent/SE8009185L/
Publication of SE451798B publication Critical patent/SE451798B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1203—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules in a form not provided for by groups A61K51/1206 - A61K51/1296, e.g. cells, cell fragments, viruses, virus capsides, ghosts, red blood cells, viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nuclear Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8009185A 1979-12-31 1980-12-30 Radioaktiv komposition innehallande indium-8-hydroxilandin och sett att merka blodceller SE451798B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/108,575 US4348375A (en) 1979-12-31 1979-12-31 Radioassay process and compositions useful therein

Publications (2)

Publication Number Publication Date
SE8009185L SE8009185L (sv) 1981-07-01
SE451798B true SE451798B (sv) 1987-11-02

Family

ID=22322962

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8009185A SE451798B (sv) 1979-12-31 1980-12-30 Radioaktiv komposition innehallande indium-8-hydroxilandin och sett att merka blodceller

Country Status (14)

Country Link
US (1) US4348375A (de)
JP (2) JPS56103118A (de)
AT (1) AT368889B (de)
BE (1) BE886930A (de)
CA (1) CA1155372A (de)
CH (1) CH652308A5 (de)
DE (1) DE3049533A1 (de)
DK (1) DK556880A (de)
ES (1) ES8202154A1 (de)
FR (1) FR2474314A1 (de)
GB (1) GB2066664B (de)
IT (1) IT1193721B (de)
NL (1) NL8007094A (de)
SE (1) SE451798B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443426A (en) * 1982-06-14 1984-04-17 Yale University Blood agent
AU580958B2 (en) * 1983-07-07 1989-02-09 Mallinckrodt, Inc. Sterile radioactive indium-containing aqueous solution
US4672028A (en) * 1984-05-23 1987-06-09 Icn Micromedic Systems, Inc. Compositions and method for simultaneous multiple array of analytes using radioisotope chelate labels
US5376356A (en) * 1989-03-14 1994-12-27 Neorx Corporation Imaging tissue sites of inflammation
US5792444A (en) * 1989-05-09 1998-08-11 The General Hospital Corporation Labeled chemotactic peptides to image focal sites of infection or inflammation
US5524622A (en) * 1994-09-20 1996-06-11 Oregon Health Sciences University Non-invasive method of determining inflammation of the gastrointestinal tract

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017596A (en) * 1975-03-03 1977-04-12 Research Corporation Radiopharmaceutical chelates and method of external imaging
CA1070695A (en) * 1975-09-02 1980-01-29 Michael D. Loberg Iminodiacetic acid pharmaceutical
FR2390408A1 (fr) * 1977-05-11 1978-12-08 Philips France Procede de marquage par un isotope radioactif d'un sel hydrosoluble d'oxine, ou de ses derives halogenes ou sulfones, produits ainsi marques, procede de marquage des elements figures du sang, et medicaments ainsi obtenus
US4335095A (en) * 1979-03-21 1982-06-15 The Radiochemical Centre Limited Indium-111 oxine complex composition

Also Published As

Publication number Publication date
CH652308A5 (de) 1985-11-15
ATA635880A (de) 1982-04-15
GB2066664B (en) 1984-06-20
IT1193721B (it) 1988-08-24
JPH02117623A (ja) 1990-05-02
JPS56103118A (en) 1981-08-18
NL8007094A (nl) 1981-08-03
CA1155372A (en) 1983-10-18
FR2474314B1 (de) 1984-10-05
SE8009185L (sv) 1981-07-01
FR2474314A1 (fr) 1981-07-31
GB2066664A (en) 1981-07-15
ES498236A0 (es) 1982-01-01
DK556880A (da) 1981-07-01
ES8202154A1 (es) 1982-01-01
IT8069013A0 (it) 1980-12-30
US4348375A (en) 1982-09-07
DE3049533A1 (de) 1981-09-17
BE886930A (fr) 1981-04-16
AT368889B (de) 1982-11-25

Similar Documents

Publication Publication Date Title
Rossen et al. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extra myocardial mechanism of ischemic injury.
EP0430968B1 (de) Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
Beller et al. Localization of radiolabeled cardiac myosin-specific antibody in myocardial infarcts. Comparison with technetium-99m stannous pyrophosphate.
Dunn et al. The disappearance rate of glutamic oxalacetic transaminase from the circulation and its distribution in the body's fluid compartments and secretions
US8097237B2 (en) Non-invasive diagnostic agents of cancer and methods of diagnosing cancer, especially leukemia and lymphoma
Fischer et al. The tissue distribution and excretion of radioactive digitoxin: studies on normal rats and cats, and rats with dietary-induced myocardial lesions
Tan et al. Studies on the site of synthesis of transcobalamin-II
US4443426A (en) Blood agent
SE451798B (sv) Radioaktiv komposition innehallande indium-8-hydroxilandin och sett att merka blodceller
Sellers et al. Determination of extravascular albumin in the rat
Puchelle et al. Rheology of sputum collected by a simple technique limiting salivary contamination
US4360509A (en) Vivo radioassay process
Thakur et al. Evaluation of indium-111-2-mercaptopyridine-N-oxide for labeling leukocytes in plasma: a kit preparation
MacDonald et al. Effect of serotonin upon liver cells of young rats.
Barth et al. Use of 99mTc as a radioisotopic label to study the migratory patterns of normal and neoplastic cells
Bergmann et al. Detection of cardiac transplant rejection with radiolabeled lymphocytes.
Handley et al. Some pharmacological properties of three new mercurial diuretics.
Allwood The migratory behavior of T blasts to contact sensitivity reactions in activelyand passively sensitized mice.
Hamilton et al. Splenic imaging with 99mTc-labeled erythrocytes: A comparative study of cell-damaging methods
US3130189A (en) Hydroxocobalamin-glutathione
Goedemans Diagnostic compositions containing a chelate of radioactive indium and 8-hydroxyquinoline
US4705678A (en) Sterile radioactive indium-containing aqueous solution
Suemasu et al. Initial stage of hematogenous metastasis of 51Cr-labeled tumor cells
Goedemans Radioassay process using an indium-8-hydroxyquinoline
Rand et al. Murine eosinophils labeled with indium-111 oxine: localization to delayed hypersensitivity reactions against a schistosomal antigen and to lymphokine in vivo

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8009185-3

Effective date: 19910704

Format of ref document f/p: F